{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T06:09:19Z","timestamp":1747202959448,"version":"3.40.5"},"reference-count":42,"publisher":"Archives of Endocrinology and Metabolism","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,7,11]]},"DOI":"10.20945\/2359-3997000000148","type":"journal-article","created":{"date-parts":[[2019,7,24]],"date-time":"2019-07-24T13:10:55Z","timestamp":1563973855000},"source":"Crossref","is-referenced-by-count":1,"title":["Postprandial metabolic effects of fructose and glucose in type 1 diabetes patients: a pilot randomized crossover clinical trial"],"prefix":"10.20945","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5149-0391","authenticated-orcid":false,"given":"D\u00e9bora Lopes","family":"Souto","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00c9rika dos Santos","family":"Lima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joana Rodrigues","family":"Dantas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1579-3299","authenticated-orcid":false,"given":"Lenita","family":"Zajdenverg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melanie","family":"Rodacki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0889-4662","authenticated-orcid":false,"given":"Eliane Lopes","family":"Rosado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"8510","reference":[{"issue":"1","key":"key20190724090303_B1","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1037\/0278-6133.8.1.45","article-title":"Mood changes associated with blood glucose fluctuations in insulin-dependent diabetes mellitus","volume":"8","author":"Gonder-Frederick","year":"1989","unstructured":"1. Gonder-Frederick LA, Cox DJ, Bobbitt SA, Pennebaker JW. Mood changes associated with blood glucose fluctuations in insulin-dependent diabetes mellitus. Health Psychol. 1989;8(1):45-59.","journal-title":"Health Psychol"},{"issue":"11","key":"key20190724090303_B2","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.2337\/diacare.15.11.1468","article-title":"Metabolic effects of dietary fructose in diabetic subjects","volume":"15","author":"Bantle","year":"1992","unstructured":"2. Bantle JP, Swanson JE, Thomas W, Laine DC. Metabolic effects of dietary fructose in diabetic subjects. Diabetes Care. 1992;15(11):1468-76.","journal-title":"Diabetes Care"},{"issue":"5","key":"key20190724090303_B3","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1111\/j.1753-4887.2005.tb00132.x","article-title":"Dietary fructose: implications for dysregulation of energy homeostasis and lipid\/carbohydrate metabolism","volume":"63","author":"Havel","year":"2005","unstructured":"3. Havel PJ. Dietary fructose: implications for dysregulation of energy homeostasis and lipid\/carbohydrate metabolism. Nutr Rev. 2005;63(5):133-57.","journal-title":"Nutr Rev"},{"issue":"6","key":"key20190724090303_B4","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1007\/s11883-012-0276-6","article-title":"Fructose and risk of cardiometabolic disease","volume":"14","author":"Bray","year":"2012","unstructured":"4. Bray GA. Fructose and risk of cardiometabolic disease. Curr Atheroscler Rep. 2012;14(6):570-8.","journal-title":"Curr Atheroscler Rep"},{"key":"key20190724090303_B5","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.2337\/dc18-S002","article-title":"Classification and diagnosis of diabetes: standards of medical care in diabetes","volume":"41","author":"American Diabetes Association","year":"2018","unstructured":"5. American Diabetes Association. Classification and diagnosis of diabetes: standards of medical care in diabetes. Diabetes Care. 2018;41(Supplement 1):S13-S27.","journal-title":"Diabetes Care"},{"issue":"2","key":"key20190724090303_B6","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1093\/ajcn\/36.2.256","article-title":"Comparison of the metabolic responses to fructose and sucrose sweetened foods","volume":"36","author":"Crapo","year":"1982","unstructured":"6. Crapo PA, Scarlett JA, Kolterman OG. Comparison of the metabolic responses to fructose and sucrose sweetened foods. Am J Clin Nutr. 1982;36(2):256-61.","journal-title":"Am J Clin Nutr"},{"issue":"1","key":"key20190724090303_B7","doi-asserted-by":"crossref","first-page":"258S","DOI":"10.1093\/ajcn\/87.1.258S","article-title":"Glycemic response and health \u2013 a systematic review and meta-analysis: relations between dietary glycemic properties and health outcomes","volume":"87","author":"Livesey","year":"2008","unstructured":"7. Livesey G, Taylor R, Hulshof T, Howlett J. Glycemic response and health \u2013 a systematic review and meta-analysis: relations between dietary glycemic properties and health outcomes. Am J Clin Nutr. 2008;87(1):258S-68S.","journal-title":"Am J Clin Nutr"},{"issue":"6654","key":"key20190724090303_B8","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1136\/bmj.297.6654.958","article-title":"Wholemeal versus wholegrain breads: proportion of whole or cracked grain and the glycaemic response","volume":"297","author":"Jenkins","year":"1988","unstructured":"8. Jenkins DJ, Wesson V, Wolever TM, Jenkins AL, Kalmusky J, Guidici S, et al. Wholemeal versus wholegrain breads: proportion of whole or cracked grain and the glycaemic response. BMJ (Clinical research ed). 1988;297(6654):958-60.","journal-title":"BMJ (Clinical research ed)"},{"key":"key20190724090303_B9","doi-asserted-by":"crossref","DOI":"10.1186\/1475-2891-11-23","article-title":"Bean and rice meals reduce postprandial glycemic response in adults with type 2 diabetes: a cross-over study","volume":"11","author":"Thompson","year":"2012","unstructured":"9. Thompson SV, Winham DM, Hutchins AM. Bean and rice meals reduce postprandial glycemic response in adults with type 2 diabetes: a cross-over study. Nutr J 2012;11:23.","journal-title":"Nutr J"},{"issue":"8","key":"key20190724090303_B10","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1249\/01.MSS.0000078924.61453.FB","article-title":"International physical activity questionnaire: 12-country reliability and validity","volume":"35","author":"Craig","year":"2003","unstructured":"10. Craig CL, Marshall AL, Sjostrom M, Bauman AE, Booth ML, Ainsworth BE, et al. International physical activity questionnaire: 12-country reliability and validity. Med Sci Sports Exerc. 2003;35(8):1381-95.","journal-title":"Med Sci Sports Exerc"},{"key":"key20190724090303_B11","author":"World Health Organization","year":"1995","unstructured":"11. World Health Organization. Physical status, the use and interpretation of anthropometry: report of a WHO expert committee: World Health Organization; 1995.","journal-title":"Physical status, the use and interpretation of anthropometry: report of a WHO expert committee"},{"key":"key20190724090303_B12","first-page":"8","author":"World Health Organization","year":"2008","unstructured":"12. World Health Organization. Waist Circumference and Waist-Hip ratio: report of a WHO Expert Consultation. 2008. World Health Organixation: Geneva. 2008:8-11.","journal-title":"Waist Circumference and Waist-Hip ratio: report of a WHO Expert Consultation"},{"issue":"4","key":"key20190724090303_B13","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1093\/ajcn\/41.4.810","article-title":"Assessment of fat-free mass using bioelectrical impedance measurements of the human body","volume":"41","author":"Lukaski","year":"1985","unstructured":"13. Lukaski HC, Johnson PE, Bolonchuk WW, Lykken GI. Assessment of fat-free mass using bioelectrical impedance measurements of the human body. Am J Clin Nutr. 1985;41(4):810-7.","journal-title":"Am J Clin Nutr"},{"issue":"6","key":"key20190724090303_B14","doi-asserted-by":"crossref","DOI":"10.1093\/clinchem\/18.6.499","article-title":"Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge","volume":"18","author":"Friedewald","year":"1972","unstructured":"14. Friedewald W, Levy R, Fredrickson D. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972;18(6):499.","journal-title":"Clin Chem"},{"issue":"1","key":"key20190724090303_B15","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1159\/000180580","article-title":"Prediction of creatinine clearance from serum creatinine","volume":"16","author":"Cockcroft","year":"1976","unstructured":"15. Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron. 1976;16(1):31-41.","journal-title":"Nephron"},{"key":"key20190724090303_B16","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.2337\/dc18-Sppc01","article-title":"Professional Practice committee: standards of medical care in diabetes","volume":"41","author":"American Diabetes Association","year":"2018","unstructured":"16. American Diabetes Association. Professional Practice committee: standards of medical care in diabetes. Diabetes Care. 2018;41(Supplement 1):S3-S.","journal-title":"Diabetes Care"},{"key":"key20190724090303_B17","doi-asserted-by":"crossref","first-page":"S120","DOI":"10.2337\/dc14-S120","article-title":"Nutrition Therapy recommendations for the management of adults with diabetes","volume":"37","author":"American Diabetes Association","year":"2014","unstructured":"17. American Diabetes Association. Nutrition Therapy recommendations for the management of adults with diabetes. Diabetes Care. 2014;37(Supplement 1):S120-S43.","journal-title":"Diabetes Care"},{"issue":"8","key":"key20190724090303_B18","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1111\/j.1464-5491.2010.02967.x","article-title":"\u2018Glycaemic variability\u2019: a new therapeutic challenge in diabetes and the critical care setting","volume":"27","author":"Ceriello","year":"2010","unstructured":"18. Ceriello A, Ihnat MA. \u2018Glycaemic variability\u2019: a new therapeutic challenge in diabetes and the critical care setting. Diabet Med. 2010;27(8):862-7.","journal-title":"Diabet Med"},{"issue":"23","key":"key20190724090303_B19","doi-asserted-by":"crossref","first-page":"3241","DOI":"10.1001\/jama.1986.03380230065027","article-title":"Metabolic effects of dietary fructose and sucrose in types I and II diabetic subjects","volume":"256","author":"Bantle","year":"1986","unstructured":"19. Bantle JP, Laine DC, Thomas JW. Metabolic effects of dietary fructose and sucrose in types I and II diabetic subjects. JAMA. 1986;256(23):3241-6.","journal-title":"JAMA"},{"issue":"4","key":"key20190724090303_B20","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1093\/ajcn\/49.4.658","article-title":"Glycemic responses in insulin-dependent diabetic patients: effect of food composition","volume":"49","author":"Hughes","year":"1989","unstructured":"20. Hughes TA, Atchison J, Hazelrig JB, Boshell BR. Glycemic responses in insulin-dependent diabetic patients: effect of food composition. Am J Clin Nutr. 1989;49(4):658-66.","journal-title":"Am J Clin Nutr"},{"issue":"7","key":"key20190724090303_B21","doi-asserted-by":"crossref","first-page":"546","DOI":"10.2337\/diacare.11.7.546","article-title":"Lack of detectable deleterious effects on metabolic control of daily fructose ingestion for 2 mo in NIDDM patients","volume":"11","author":"Grigoresco","year":"1988","unstructured":"21. Grigoresco C, Rizkalla SW, Halfon P, Bornet F, Fontvieille AM, Bros M, et al. Lack of detectable deleterious effects on metabolic control of daily fructose ingestion for 2 mo in NIDDM patients. Diabetes Care. 1988;11(7):546-50.","journal-title":"Diabetes Care"},{"issue":"11","key":"key20190724090303_B22","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.2337\/diacare.19.11.1249","article-title":"Metabolic effects of dietary sucrose and fructose in type II diabetic subjects","volume":"19","author":"Malerbi","year":"1996","unstructured":"22. Malerbi DA, Paiva ES, Duarte AL, Wajchenberg BL. Metabolic effects of dietary sucrose and fructose in type II diabetic subjects. Diabetes Care. 1996;19(11):1249-56.","journal-title":"Diabetes Care"},{"key":"key20190724090303_B23","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.2337\/dc13-2339","article-title":"Response to comment on kramer et al. Glucagon response to oral glucose challenge in type 1 diabetes: lack of impact of euglycemia","volume":"37","author":"Kramer","year":"2014","unstructured":"23. Kramer CK, Retnakaran R, Zinman B. Response to comment on kramer et al. Glucagon response to oral glucose challenge in type 1 diabetes: lack of impact of euglycemia. Diabetes Care. 2014;37:1076-1082. Diabetes Care. 2014;37(9):e209.","journal-title":"Diabetes Care"},{"issue":"4","key":"key20190724090303_B24","doi-asserted-by":"crossref","first-page":"893","DOI":"10.2337\/diabetes.51.4.893","article-title":"Fructose amplifies counterregulatory responses to hypoglycemia in humans","volume":"51","author":"Gabriely","year":"2002","unstructured":"24. Gabriely I, Hawkins M, Vilcu C, Rossetti L, Shamoon H. Fructose amplifies counterregulatory responses to hypoglycemia in humans. Diabetes. 2002;51(4):893-900.","journal-title":"Diabetes"},{"issue":"8","key":"key20190724090303_B25","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.2337\/dc11-2010","article-title":"Early loss of the glucagon response to hypoglycemia in adolescents with type 1 diabetes","volume":"35","author":"Siafarikas","year":"2012","unstructured":"25. Siafarikas A, Johnston RJ, Bulsara MK, O\u2019Leary P, Jones TW, Davis EA. Early loss of the glucagon response to hypoglycemia in adolescents with type 1 diabetes. Diabetes Care. 2012;35(8):1757-62.","journal-title":"Diabetes Care"},{"issue":"7","key":"key20190724090303_B26","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.2337\/dc08-0575","article-title":"Too much glucagon, too little insulin: time course of pancreatic islet dysfunction in new-onset type 1 diabetes","volume":"31","author":"Brown","year":"2008","unstructured":"26. Brown RJ, Sinaii N, Rother KI. Too much glucagon, too little insulin: time course of pancreatic islet dysfunction in new-onset type 1 diabetes. Diabetes Care. 2008;31(7):1403-4.","journal-title":"Diabetes Care"},{"issue":"4","key":"key20190724090303_B27","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/S0022-3476(77)80363-6","article-title":"Suppressibility of glucagon secretion by glucose in juvenile diabetes","volume":"90","author":"Sperling","year":"1977","unstructured":"27. Sperling MA, Aleck K, Voina S. Suppressibility of glucagon secretion by glucose in juvenile diabetes. J Pediatr. 1977;90(4):543-7.","journal-title":"J Pediatr"},{"key":"key20190724090303_B28","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.d1855","article-title":"Overnight closed loop insulin delivery (artificial pancreas) in adults with type 1 diabetes: crossover randomised controlled studies","volume":"342","author":"Hovorka","year":"2011","unstructured":"28. Hovorka R, Kumareswaran K, Harris J, Allen JM, Elleri D, Xing D, et al. Overnight closed loop insulin delivery (artificial pancreas) in adults with type 1 diabetes: crossover randomised controlled studies. BMJ (Clinical research ed). 2011;342:d1855.","journal-title":"BMJ (Clinical research ed)"},{"issue":"4","key":"key20190724090303_B29","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1503\/cmaj.121265","article-title":"Glucose-responsive insulin and glucagon delivery (dual-hormone artificial pancreas) in adults with type 1 diabetes: a randomized crossover controlled trial","volume":"185","author":"Haidar","year":"2013","unstructured":"29. Haidar A, Legault L, Dallaire M, Alkhateeb A, Coriati A, Messier V, et al. Glucose-responsive insulin and glucagon delivery (dual-hormone artificial pancreas) in adults with type 1 diabetes: a randomized crossover controlled trial. CMAJ. 2013;185(4):297-305.","journal-title":"CMAJ"},{"issue":"9","key":"key20190724090303_B30","doi-asserted-by":"crossref","first-page":"e149","DOI":"10.2337\/dc13-0866","article-title":"Fructose-induced hyperuricemia is associated with a decreased renal uric acid excretion in humans","volume":"36","author":"Lecoultre","year":"2013","unstructured":"30. Lecoultre V, Egli L, Theytaz F, Despland C, Schneiter P, Tappy L. Fructose-induced hyperuricemia is associated with a decreased renal uric acid excretion in humans. Diabetes Care. 2013;36(9):e149-50.","journal-title":"Diabetes Care"},{"issue":"1","key":"key20190724090303_B31","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1210\/er.2008-0033","article-title":"Hypothesis: could excessive fructose intake and uric acid cause type 2 diabetes?","volume":"30","author":"Johnson","year":"2009","unstructured":"31. Johnson RJ, Perez-Pozo SE, Sautin YY, Manitius J, Sanchez-Lozada LG, Feig DI, et al. Hypothesis: could excessive fructose intake and uric acid cause type 2 diabetes? Endocr Rev. 2009;30(1):96-116.","journal-title":"Endocr Rev"},{"issue":"2","key":"key20190724090303_B32","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1159\/000186728","article-title":"Urine uric acid excretion in patients with insulin-dependent diabetes mellitus","volume":"60","author":"Erdberg","year":"1992","unstructured":"32. Erdberg A, Boner G, van Dyk DJ, Carel R. Urine uric acid excretion in patients with insulin-dependent diabetes mellitus. Nephron. 1992;60(2):134-7.","journal-title":"Nephron"},{"issue":"1","key":"key20190724090303_B33","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0086963","article-title":"Mathematical modeling of renal tubular glucose absorption after glucose load","volume":"9","author":"De Gaetano","year":"2014","unstructured":"33. De Gaetano A, Panunzi S, Eliopoulos D, Hardy T, Mingrone G. Mathematical modeling of renal tubular glucose absorption after glucose load. PLoS One. 2014;9(1):e86963.","journal-title":"PLoS One"},{"issue":"733","key":"key20190724090303_B34","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1136\/pgmj.62.733.1001","article-title":"Serum uric acid, serum glucose and diabetes: relationships in a population study","volume":"62","author":"Cook","year":"1986","unstructured":"34. Cook DG, Shaper AG, Thelle DS, Whitehead TP. Serum uric acid, serum glucose and diabetes: relationships in a population study. Postgrad Med J. 1986;62(733):1001-6.","journal-title":"Postgrad Med J"},{"issue":"26","key":"key20190724090303_B35","doi-asserted-by":"crossref","first-page":"2448","DOI":"10.1016\/j.lfs.2006.08.009","article-title":"Fructose-induced peroxynitrite production is mediated by methylglyoxal in vascular smooth muscle cells","volume":"79","author":"Wang","year":"2006","unstructured":"35. Wang H, Meng QH, Chang T, Wu L. Fructose-induced peroxynitrite production is mediated by methylglyoxal in vascular smooth muscle cells. Life Sci. 2006;79(26):2448-54.","journal-title":"Life Sci"},{"key":"key20190724090303_B36","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.ab.2016.10.021","article-title":"Assessment of lipid peroxidation by measuring malondialdehyde (MDA) and relatives in biological samples: Analytical and biological challenges","volume":"524","author":"Tsikas","year":"2017","unstructured":"36. Tsikas D. Assessment of lipid peroxidation by measuring malondialdehyde (MDA) and relatives in biological samples: Analytical and biological challenges. Anal Biochem. 2017;524:13-30.","journal-title":"Anal Biochem"},{"issue":"4","key":"key20190724090303_B37","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.2337\/diabetes.51.4.1118","article-title":"Xanthine oxidase is involved in free radical production in type 1 diabetes: protection by allopurinol","volume":"51","author":"Desco","year":"2002","unstructured":"37. Desco M-C, Asensi M, M\u00e1rquez R, Mart\u00ednez-Valls J, Vento M, Pallard\u00f3 FV, et al. Xanthine oxidase is involved in free radical production in type 1 diabetes: protection by allopurinol. Diabetes. 2002;51(4):1118-24.","journal-title":"Diabetes"},{"issue":"1","key":"key20190724090303_B38","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s00467-008-0961-4","article-title":"Oxidant\/antioxidant status and hyperfiltration in young patients with type 1 diabetes mellitus","volume":"24","author":"Hernandez-Marco","year":"2009","unstructured":"38. Hernandez-Marco R, Codoner-Franch P, Pons Morales S, Del Castillo Villaescusa C, Boix Garcia L, Valls Belles V. Oxidant\/antioxidant status and hyperfiltration in young patients with type 1 diabetes mellitus. Pediatr Nephrol. 2009;24(1):121-7.","journal-title":"Pediatr Nephrol"},{"issue":"1","key":"key20190724090303_B39","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s10286-010-0084-4","article-title":"Oxidative stress and autonomic nerve function in early type 1 diabetes","volume":"21","author":"Hoeldtke","year":"2011","unstructured":"39. Hoeldtke RD, Bryner KD, VanDyke K. Oxidative stress and autonomic nerve function in early type 1 diabetes. Clin Auton Res. 2011;21(1):19-28.","journal-title":"Clin Auton Res"},{"issue":"1","key":"key20190724090303_B40","first-page":"42","article-title":"Physiological taste threshold in type 1 diabetes mellitus","volume":"56","author":"Khobragade","year":"2012","unstructured":"40. Khobragade RS, Wakode SL, Kale AH. Physiological taste threshold in type 1 diabetes mellitus. Indian J Physiol Pharmacol. 2012;56(1):42-7.","journal-title":"Indian J Physiol Pharmacol"},{"key":"key20190724090303_B41","article-title":"Sample size determination in health studies: a practical manual\/SK Lwanga and S","author":"Lwanga","year":"1991","unstructured":"41. Lwanga SK, Lemeshow S. Sample size determination in health studies: a practical manual\/SK Lwanga and S. Lemeshow. 1991.","journal-title":"Lemeshow"},{"issue":"4","key":"key20190724090303_B42","article-title":"How study design affects outcomes in comparisons of therapy","volume":"8","author":"Colditz","year":"1989","unstructured":"42. Colditz G, Miller J, Mosteller F. How study design affects outcomes in comparisons of therapy. I: Medical. Stat Med. 1989;8(4):441.","journal-title":"I: Medical. Stat Med"}],"container-title":["Archives of Endocrinology and Metabolism"],"original-title":[],"language":"en","deposited":{"date-parts":[[2021,1,14]],"date-time":"2021-01-14T04:37:59Z","timestamp":1610599079000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S2359-39972019005006102&lng=en&nrm=iso&tlng=en"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,11]]},"references-count":42,"alternative-id":["10.20945\/2359-3997000000148"],"URL":"https:\/\/doi.org\/10.20945\/2359-3997000000148","relation":{},"ISSN":["2359-3997","2359-4292"],"issn-type":[{"type":"print","value":"2359-3997"},{"type":"electronic","value":"2359-4292"}],"subject":[],"published":{"date-parts":[[2019,7,11]]}}}